This website uses cookies to function correctly.
You may delete cookies at any time but doing so may result in some parts of the site not working correctly.

Changes to Injector Adrenaline Pens - Epipen®/Jext®/Emerade® - June 2016

As part of a review to bring prescribing into line with national recommendations and guidelines, the CCG is making a change in the first line choice brand of emergency treatment of anaphylaxis. 

After careful consideration we have decided to change the treatment pen you receive. This will mean that the next time you collect your repeat prescription it will be for a product called Emerade® instead of Jext® or Epipen®

Your new medication, Emerade®, works in exactly the same way and contains exactly the same medication as your current device, but is more simple and safer to use.

Please do not worry that the pen device is different to your current pen, this does NOT mean that your adrenaline treatment has changed, it is simply the administration device that is different. The additional advantage is that your pen will have a longer expiry date, with 12 months longer shelf life than Jext® and Epipen®, which means that you will not need to renew your prescription as frequently.

Please see this leaflet for more information including instructions. You can also watch a short demo video on the Emerade® website here. You can also ask your pharmacist for a new medication service (NMS) review where they will demonstrate how to use the new pen and answer your questions. If you still have any concerns then please do contact the surgery.

Call 111 when you need medical help fast but it’s not a 999 emergencyNHS ChoicesThis site is brought to you by My Surgery Website